Testing the Addition of an Anti-Cancer Drug, Camonsertib, to Radiation Therapy for Recurrent Head and Neck Squamous Cell Carcinoma
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Vanderbilt-Ingram Cancer Center
EpiBiologics
Fox Chase Cancer Center
Radiopharm Theranostics, Ltd
NYU Langone Health
UNC Lineberger Comprehensive Cancer Center
Qilu Pharmaceutical Co., Ltd.
Dartmouth-Hitchcock Medical Center
AccSalus Biosciences, Inc.
Petrov, Andrey
Case Comprehensive Cancer Center
Beijing Tongren Hospital
Shanghai Bao Pharmaceuticals Co., Ltd.
Corregene Biotechnology Co., Ltd
Mabpro, a.s.